NCT05061290

Brief Summary

Iron-deficient anemia is a chronic problem in sub-Saharan Africa and other developing areas of the world. From our previous research, the investigators have shown that certain local plant foods in Kenya and Senegal have an unusual action of improving in vitro iron bioaccessibility (nearly doubling the low value obtained in cereals). The investigators will assess absorption of stable isotopes of iron (57Fe, 54Fe and 58Fe) extrinsically labeled in a serving of porridge fortified with various combinations of moringa, baobab, mango, carrot and standard fortificant iron sulfate and the enhancer ascorbic acid.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 20, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 29, 2021

Completed
1.1 years until next milestone

Study Start

First participant enrolled

November 1, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2023

Completed
Last Updated

September 28, 2022

Status Verified

September 1, 2022

Enrollment Period

3 months

First QC Date

September 20, 2021

Last Update Submit

September 26, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Iron absorption

    Assessment whole blood for isotopic iron absorption from individual meals

    Acute study but blood measurement to occur following 14 daysof acute consumption

Study Arms (5)

Control Porridge

EXPERIMENTAL

Wholegrain maize flour, Mango powder, Carrot powder, Ferrous sulfate, Corn starch

Other: Control Porridge

Reference Porride A

EXPERIMENTAL

Wholegrain maize flour, Mango powder, Carrot powder, Ferrous sulfate, Ascorbic acid, Corn starch

Other: Reference Porridge A

Test Porridge B

EXPERIMENTAL

Wholegrain maize flour, Moringa leaf powder, Mango powder, Carrot powder, Corn starch

Other: Test Porridge B

Test Porridge C

EXPERIMENTAL

Wholegrain maize flour, Baobab fruit powder, Mango powder, Carrot powder, Ferrous sulfate, Corn starch

Other: Test Porridge C

Test Porridge D

EXPERIMENTAL

Wholegrain maize flour, Baobab fruit powder, Moringa leaf powder, Mango powder, Carrot powder

Other: Test Porridge D

Interventions

Maize porridge containing 54Fe as iron sulfate

Control Porridge

Maize porridge counting 58Fe as iron sulfate with ascorbic acid

Reference Porride A

Maize porridge containing 57Fe and fortified with Moringa leaf powder as iron source

Test Porridge B

Maize porridge containing 57Fe and fortified with Boabab fruit powder as iron source

Test Porridge C

Maize porridge containing 54Fe and fortified with Moringa leaf and Baobab fruit powder as iron source

Test Porridge D

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female 18-65 Y
  • BMI 18.5-25 kg/m2
  • Stable weight past 3 month (+/- 2.5kg)
  • Clinically normal blood profiles
  • Fasting blood glucose \< 110 and CRP below 3 mg/L

You may not qualify if:

  • Smokers and vapers
  • No heavy alcohol consumption (\>2 drinks per day)
  • Diabetic
  • Presence of metabolic of intestinal disorder including lipid malabsorption or lactose intolerance
  • Male sex
  • Pregnant
  • Lactating
  • Long term use of medications
  • Blood donation in past 4 months
  • Previous participation in iron stable isotope bioavailability study
  • Following a weight reduction program or having one in past 3 months
  • Peri- or post-menopausal
  • Acute or chronic disease
  • Hypertension

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Purdue University

West Lafayette, Indiana, 47907, United States

Location

Central Study Contacts

Bruce Hamaker

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 20, 2021

First Posted

September 29, 2021

Study Start

November 1, 2022

Primary Completion

February 1, 2023

Study Completion

February 1, 2023

Last Updated

September 28, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared with other researchers

Locations